Parabilis Medicines, Inc. Common Stock (PBLS) — Defensive Interval Ratio
Parabilis Medicines, Inc. Common Stock (PBLS) has a Defensive Interval Ratio of 0 days as of December 2025. Defensive assets of $0.00 (cash $-, short-term investments $0.00, receivables $-) cover 0 days of daily cash needs of $155.59K/day. See Parabilis Medicines, Inc. Common Stock (PBLS) working capital ratio to evaluate short-term liquidity relative to the company's equity base.
Defensive Interval Ratio
Defensive Assets
Daily Cash Need
Current Liabilities
Parabilis Medicines, Inc. Common Stock Defensive Interval Ratio (2024–2025)
This chart shows how Parabilis Medicines, Inc. Common Stock's Defensive Interval Ratio has evolved across 2 annual periods from 2024 to 2025. As of December 2025, the ratio stands at 0 days, meaning defensive assets of $0.00 can fund 0 days of operations without new revenue. See Parabilis Medicines, Inc. Common Stock (PBLS) balance sheet quality index to measure how much of total assets are equity-financed.
Annual Defensive Interval Ratio for Parabilis Medicines, Inc. Common Stock (2024–2025)
The table below presents the year-by-year Defensive Interval Ratio for Parabilis Medicines, Inc. Common Stock from 2024 to 2025, covering 2 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. For live market cap and the full company financial profile, see PBLS stock market capitalisation.
| Year | DIR (days) | Defensive Assets (USD) | Daily Cash Need | Cash | ST Investments | Change (days) |
|---|---|---|---|---|---|---|
| 2025 | 0 days | $0.00 | $155.59K/day | $- | $0.00 | ▼ -458 days |
| 2024 | 458 days | $40.69 Million | $88.80K/day | $- | $40.69 Million | — |